Credit Suisse Ag Invitae Corp Put Options Transaction History

Credit Suisse Ag

  • $101 Billion
  • Q1 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2021

Aug 16, 2021
BUY
$26.09 - $40.4 $391,350 - $606,000
15,000 Added 11.44%
146,100 $4.98 Million
Q1 2021

May 14, 2021
BUY
$33.06 - $56.93 $1.97 Million - $3.39 Million
59,600 Added 83.36%
131,100 $5.01 Million
Q4 2020

Feb 12, 2021
BUY
$39.09 - $57.4 $2.79 Million - $4.1 Million
71,500 New
71,500 $2.99 Million

Others Institutions Holding NVTA

# of Institutions
20
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email